Ionis Pharmaceuticals, Inc. (IONS)
85.45
+0.85
(+1.00%)
USD |
NASDAQ |
Feb 24, 16:00
85.45
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals Total Liabilities (Quarterly) : 2.415B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 11.18B |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Twist Bioscience Corp. | 181.99M |
| Catalyst Pharmaceuticals, Inc. | 131.36M |
| Cytokinetics, Inc. | 1.958B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.033B |
| Shareholders Equity (Quarterly) | 617.97M |
| Debt to Equity Ratio | 3.315 |
| Current Ratio | 2.788 |
| Net Debt Paydown Yield | -0.14% |